Learn about UCSF’s response to the coronavirus outbreak, important updates on campus safety precautions, and the latest policies and guidance on our COVID-19 resource website. You can also access information from the CDC. Learn more
UCSF infectious disease scientists have released preliminary results of blood tests for COVID-19 antibodies conducted as part of a community-led project to provide comprehensive COVID-19 testing to residents of Bolinas.
The collaboration is part of UCSF’s tightly coordinated work with the San Francisco Department of Public Health, the state of California, and affected communities to respond to the public health crisis presented by COVID-19.
UCSF epidemiologists and infectious disease specialists are partnering with several community organizations and the San Francisco Department of Public Health to offer comprehensive, voluntary COVID-19 testing to residents of the Bayview, Sunnydale and Visitacion Valley.
As cases of COVID-19 continue to mount in Navajo Nation, UC San Francisco is sending a second team of health care workers — 13 nurses and six physicians — to Arizona to help provide urgently needed support to the largest hospitals serving Navajo patients.
Amid so little good news, early clinical trial results for the anti-viral drug remdesivir have offered hope. The drug appeared to help patients recover faster, from 15 days to 11 days. But the newest obstacle may be the uncertainty that surrounds how the drug will be distributed to patients.
A product containing healthy vaginal bacteria has proved effective against recurrent bacterial vaginosis (BV), an extremely common vaginal infection that is associated with preterm birth, HIV infection and problems with in vitro fertilization.